Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MabVax Therapeutics Holdings Inc (NASDAQ:MBVX)

0.88
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
0.43
Today|||52-Week Range
3.57
+25.71%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Hansen John David
President & Chief Executive Officer
Sale1/10/2018110,093$0.96$105.7K-7.36%
Hanson Gregory P
Chief Financial Officer & Secretary
Sale1/10/201866,550$0.96$63.9K-7.36%
Hansen John David
President & Chief Executive Officer
Sale1/11/201864,015$0.98$62.7K-10.24%
Maffuid Paul W
Executive Vice President
Sale1/10/201860,478$0.96$58.1K-7.36%
Hanson Gregory P
Chief Financial Officer & Secretary
Sale1/11/201838,697$0.98$37.9K-10.24%
Maffuid Paul W
Executive Vice President
Sale1/11/201835,166$0.98$34.5K-10.24%
Hansen John David
President & Chief Executive Officer
Sale4/12/201710,216$2.00$20.4K-56.65%
Livingston Philip O /mabvax/
Chief Scientific Officer
Sale1/10/201821,155$0.96$20.3K-7.36%
Hansen John David
President & Chief Executive Officer
Sale1/12/201818,582$0.96$17.8K-1.83%
Livingston Philip O /mabvax/
Chief Scientific Officer
Sale1/11/201812,301$0.98$12.1K-10.24%
Page of 6